424 related articles for article (PubMed ID: 26253244)
21. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P
Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385
[TBL] [Abstract][Full Text] [Related]
22. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer.
Zhang XM; Fan H; Kou JT; Zhang XX; Li P; Dai Y; He Q
J Gastroenterol Hepatol; 2016 Aug; 31(8):1498-503. PubMed ID: 26825612
[TBL] [Abstract][Full Text] [Related]
23. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
24. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?
Turrini O; Ewald J; Barbier L; Mokart D; Blache JL; Delpero JR
Ann Surg; 2013 Apr; 257(4):726-30. PubMed ID: 22968078
[TBL] [Abstract][Full Text] [Related]
25. Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy.
Lee DY; Mitchell EL; Jones MA; Landry GJ; Liem TK; Sheppard BC; Billingsley KG; Moneta GL
J Vasc Surg; 2010 Mar; 51(3):662-6. PubMed ID: 20080375
[TBL] [Abstract][Full Text] [Related]
26. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
27. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
Wang J; Estrella JS; Peng L; Rashid A; Varadhachary GR; Wang H; Lee JE; Pisters PW; Vauthey JN; Katz MH; Gomez HF; Evans DB; Abbruzzese JL; Fleming JB; Wang H
Cancer; 2012 Aug; 118(15):3801-11. PubMed ID: 22180096
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
Michalski CW; Kong B; Jäger C; Kloe S; Beier B; Braren R; Esposito I; Erkan M; Friess H; Kleeff J
BMC Surg; 2015 Aug; 15():100. PubMed ID: 26296752
[TBL] [Abstract][Full Text] [Related]
29. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
30. Vascular invasion in pancreatic cancer: tumor biology or tumor topography?
Rehders A; Stoecklein NH; Güray A; Riediger R; Alexander A; Knoefel WT
Surgery; 2012 Sep; 152(3 Suppl 1):S143-51. PubMed ID: 22766363
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.
Imamura T; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Todaka A; Fukutomi A; Aramaki T; Uesaka K
Br J Surg; 2019 Nov; 106(12):1649-1656. PubMed ID: 31626342
[TBL] [Abstract][Full Text] [Related]
32. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Kozuki A; Saisaka Y; Tokumaru T; Iiyama T; Noda Y; Hata Y; Matsumoto M
Langenbecks Arch Surg; 2015 May; 400(4):487-94. PubMed ID: 25940756
[TBL] [Abstract][Full Text] [Related]
33. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
[TBL] [Abstract][Full Text] [Related]
34. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
[TBL] [Abstract][Full Text] [Related]
35. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.
Prakash LR; Wang H; Zhao J; Nogueras-Gonzalez GM; Cloyd JM; Tzeng CD; Kim MP; Lee JE; Katz MHG
J Gastrointest Surg; 2020 Feb; 24(2):368-379. PubMed ID: 30820801
[TBL] [Abstract][Full Text] [Related]
36. The importance of invasion and resection of superior mesenteric and portal veins in adenocarcinoma of the pancreas.
Aktekin A; Küçük M; Odabaşi M; Muftuoglu T; Gürleyik G; Özkara S; Aker F; Saglam A
Hepatogastroenterology; 2013; 60(125):1194-8. PubMed ID: 23803382
[TBL] [Abstract][Full Text] [Related]
37. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
38. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
Shimoda M; Mori S; Kita J; Sawada T; Kubota K
Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
[TBL] [Abstract][Full Text] [Related]
39. Defining venous involvement in borderline resectable pancreatic cancer.
Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
Shimada K; Sakamoto Y; Sano T; Kosuge T
Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
